Abstract

Purinergic receptor stimulation has potential therapeutic effects for cystic fibrosis (CF). Thus, we explored roles for P2Y and P2X receptors in stably increasing [Ca(2+)](i) in human CF (IB3-1) and non-CF (16HBE14o(-)) airway epithelial cells. Cytosolic Ca(2+) was measured by fluorospectrometry using the fluorescent dye Fura-2/AM. Expression of P2X receptor (P2XR) subtypes was assessed by immunoblotting and biotinylation. In IB3-1 cells, ATP and other P2Y agonists caused only a transient increase in [Ca(2+)](i) derived from intracellular stores in a Na(+)-rich environment. In contrast, ATP induced an increase in [Ca(2+)](i) that had transient and sustained components in a Na(+)-free medium; the sustained plateau was potentiated by zinc or increasing extracellular pH. Benzoyl-benzoyl-ATP, a P2XR-selective agonist, increased [Ca(2+)](i) only in Na(+)-free medium, suggesting competition between Na(+) and Ca(2+) through P2XRs. Biochemical evidence showed that the P2X(4) receptor is the major subtype shared by these airway epithelial cells. A role for store-operated Ca(2+) channels, voltage-dependent Ca(2+) channels, or Na(+)/Ca(2+) exchanger in the ATP-induced sustained Ca(2+) signal was ruled out. In conclusion, these data show that epithelial P2X(4) receptors serve as ATP-gated calcium entry channels that induce a sustained increase in [Ca(2+)](i). In airway epithelia, a P2XR-mediated Ca(2+) signal may have therapeutic benefit for CF.

Highlights

  • In cystic fibrosis (CF),1 cyclic AMP- and protein kinase A-dependent transepithelial ClϪ transport is impaired because of mutations in the CF gene that encodes for the protein, the “cystic fibrosis transmembrane conductance regulator” or CFTR [1]

  • The exact mechanisms of the regulation of these proteins by CFTR are not yet fully understood, it is clear that impaired ClϪ transport is shared as a key disease phenotype by CF epithelia from all affected tissues and that this pathway is lost in CF

  • Recent data [57] indicate that 2MeSATP and, possibly, ADP␤S at a concentration of 100 ␮M may activate P2Y11 receptors, we believe it is very unlikely that the increase in [Ca2ϩ]i observed in this study was due to the activation of P2Y11 receptors

Read more

Summary

Introduction

In cystic fibrosis (CF), cyclic AMP- and protein kinase A-dependent transepithelial ClϪ transport is impaired because of mutations in the CF gene that encodes for the protein, the “cystic fibrosis transmembrane conductance regulator” or CFTR [1]. The exact mechanisms of the regulation of these proteins by CFTR are not yet fully understood, it is clear that impaired ClϪ transport is shared as a key disease phenotype by CF epithelia from all affected tissues and that this pathway is lost in CF. Stimulation of Ca2ϩ-dependent ClϪ channels can correct the impaired HCO3Ϫ secretion in CF cells [6, 7]. ATP is released into the extracellular space, it can bind to purinoceptors regulating a variety of functions in different epithelia [13,14,15]. ATP and other agonists of purinoceptors are known to increase intracellular Ca2ϩ concentration ([Ca2ϩ]i) potently in airway epithelial cells which, in turn, leads to stimulation of ClϪ secretion (14 –17) and inhibition of Naϩ absorption (18 –22).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call